ANIK   $25.475  0.85% Market Open

Anika Therapeutics Inc
Last Events:

2023-08-09 Signal in Stochastic changed from bearish weakening to bearish recovery. The stochastic indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: main and signal line crossing.

2023-08-06 Signal in RSI changed from bearish weakening to bearish recovery. RSI indicator is in the oversold territory and it heading south. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: exit from the overbought zone.

2023-08-05 Signal in Stochastic changed from bearish recovery to bearish weakening. The stochastic indicator is in the oversold territory and it grows. These factors indicate that perhaps the downside trend is coming to an end. Last signal: main and signal line crossing.

2023-08-05 Signal in RSI changed from bearish recovery to bearish weakening. RSI indicator is in the oversold territory and it heading north. These factors indicate that perhaps the downside trend is coming to an end. Last signal: exit from the overbought zone.

2023-08-03 Trend Power changed from medium strength to strong.

2023-07-30 Trend pattern changed from канал to нисходящий треугольник.

2023-07-29 Trend pattern changed from расширяющаяся формация to канал.

2023-07-29 Signal in MACD changed from bearish weakening to bearish recovery. Oscillator MACD is in the negative territory it's higher than the signal line and falls. These factors mean that negative mood prevails, but this trend does not have a significant strength. Last signal: main and signal line crossing.


Current temperature: 11.12
ST: 0, Cor:

50-50 Year Forecast
Low with % probability:
Target: 24.12
High with % probability:
Analyst Recommendations:
Number of estimates 2
Target Price Mean 34.50
Mean unverified/preliminary 34.50 / 34.50
Target Price Low / High 32.00 / 37.00
Median / STD DEV 34.50 / 3.54
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total None ActivelyBuy None
rsi None ActivelyBuy None
macd None None None
stoch None None None
ma20 Sell ActivelyBuy None
ma50 None None None
ma100 None Buy None
Candlestick PatternSept. 18, 2024 Three Gaps Up - pattern is a made up of four white candlesticks. Pattern appears on a downtrend and consists of three consecutive days each gapping higher on the open. Considered to be a bearish reversal pattern.
ISIN US0352551081
ceo Dr. Cheryl Renee Blanchard Ph.D.
Website https://www.anika.com
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products includes Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide both short- and long-term pain relief. The company's joint preservation and restoration product family comprises and orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions used to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants, which are designed to treat upper and lower extremity orthopedic conditions. In addition, it offers non-orthopedic products comprising HA-based products for non-orthopedic applications including Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier indicated for use after abdominal-pelvic surgeries; and Hyalomatrix used for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic products. The company was founded in 1983 and is headquartered in Bedford, Massachusetts.